These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18647945)

  • 1. Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programmes.
    Alexander JA; Wells R; Jiang L; Pollack H
    Health Serv Manage Res; 2008 Aug; 21(3):168-77. PubMed ID: 18647945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do resource dependencies affect treatment practices? The case of outpatient substance abuse treatment programs.
    Alexander JA; Wells R
    Med Care Res Rev; 2008 Dec; 65(6):729-47. PubMed ID: 18658141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How outpatient substance abuse treatment unit director activities may affect provision of community outreach services.
    Chuang E; Wells R; Alexander J; Green S
    Drugs (Abingdon Engl); 2013 Apr; 20(2):149-159. PubMed ID: 29170607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage to medical services in the Drug Abuse Treatment Outcome Study.
    Friedmann PD; Lemon SC; Stein MD; Etheridge RM; D'Aunno TA
    Med Care; 2001 Mar; 39(3):284-95. PubMed ID: 11242322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory study of alternative configurations of governing boards of substance abuse treatment centers.
    Fields D; Blum TC; Roman PM
    J Subst Abuse Treat; 2011 Sep; 41(2):156-68. PubMed ID: 21489737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between U.S. substance abuse treatment facilities that do and do not offer domestic violence services.
    Cohn A; Najavits LM
    Psychiatr Serv; 2014 Apr; 65(4):504-10. PubMed ID: 24430366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with interorganizational relationships among outpatient drug treatment organizations 1990-2000.
    Wells R; Lemak CH; D'Aunno TA
    Health Serv Res; 2005 Oct; 40(5 Pt 1):1356-78. PubMed ID: 16174138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the service linkages of substance abuse agencies with mental health and primary care organizations.
    Lee SY; Morrissey JP; Thomas KC; Carter WC; Ellis AR
    Am J Drug Alcohol Abuse; 2006; 32(1):69-86. PubMed ID: 16450644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community referral sources and entry of treatment-naive clients into outpatient addiction treatment.
    Friedmann PD; Lemon SC; Stein MD; D'Aunno TA
    Am J Drug Alcohol Abuse; 2003; 29(1):105-15. PubMed ID: 12731683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administrative burden and its implications for outpatient substance abuse treatment organizations.
    Lemak CH; Alexander JA; Campbell C
    Psychiatr Serv; 2003 May; 54(5):705-11. PubMed ID: 12719502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational determinants of outpatient substance abuse treatment duration in women.
    Campbell CI; Alexander JA; Lemak CH
    J Subst Abuse Treat; 2009 Jul; 37(1):64-72. PubMed ID: 19038526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment effectiveness of outpatient substance misuse treatment organizations between court-mandated and voluntary clients.
    Howard DL; McCaughrin WC
    Subst Use Misuse; 1996 May; 31(7):895-926. PubMed ID: 8776807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.